23.82
Overview
News
Price History
Option Chain
Why PHG Down?
Discussions
Forecast
Stock Split
Dividend History
Koninklijke Philips N V Adr stock is traded at $23.82, with a volume of 407.08K.
It is up +0.08% in the last 24 hours and down -10.99% over the past month.
Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. Around 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (around 30% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products.
See More
Previous Close:
$23.79
Open:
$23.88
24h Volume:
407.08K
Relative Volume:
0.46
Market Cap:
$22.01B
Revenue:
$19.56B
Net Income/Loss:
$-358.43M
P/E Ratio:
-65.60
EPS:
-0.3631
Net Cash Flow:
-
1W Performance:
+9.88%
1M Performance:
-10.99%
6M Performance:
-25.89%
1Y Performance:
+20.64%
Koninklijke Philips N V Adr Stock (PHG) Company Profile
Name
Koninklijke Philips N V Adr
Sector
Industry
Phone
-
Address
-
Compare PHG with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
PHG
Koninklijke Philips N V Adr
|
23.84 | 22.01B | 19.56B | -358.43M | 0 | -0.3631 |
![]()
ABT
Abbott Laboratories
|
126.03 | 220.60B | 41.95B | 13.40B | 6.35B | 7.65 |
![]()
BSX
Boston Scientific Corp
|
94.13 | 140.08B | 16.75B | 1.85B | 2.37B | 1.25 |
![]()
SYK
Stryker Corp
|
347.07 | 134.40B | 22.60B | 2.99B | 3.49B | 7.76 |
![]()
MDT
Medtronic Plc
|
82.88 | 107.53B | 33.20B | 4.26B | 5.47B | 3.29 |
![]()
EW
Edwards Lifesciences Corp
|
70.70 | 41.23B | 5.72B | 4.17B | 259.90M | 6.97 |
Koninklijke Philips N V Adr Stock (PHG) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Feb-25-25 | Upgrade | Exane BNP Paribas | Neutral → Outperform |
Feb-20-25 | Upgrade | UBS | Neutral → Buy |
Oct-29-24 | Upgrade | Jefferies | Underperform → Hold |
May-13-24 | Upgrade | Bernstein | Mkt Perform → Outperform |
May-07-24 | Upgrade | Exane BNP Paribas | Underperform → Neutral |
Apr-30-24 | Upgrade | JP Morgan | Underweight → Neutral |
Apr-30-24 | Upgrade | UBS | Sell → Neutral |
Feb-07-24 | Downgrade | Exane BNP Paribas | Outperform → Underperform |
Jul-12-23 | Initiated | Goldman | Buy |
Jan-17-23 | Downgrade | UBS | Neutral → Sell |
Oct-18-22 | Initiated | Morgan Stanley | Equal-Weight |
Oct-14-22 | Downgrade | Deutsche Bank | Hold → Sell |
Sep-12-22 | Upgrade | Societe Generale | Hold → Buy |
Sep-06-22 | Upgrade | UBS | Sell → Neutral |
Jul-25-22 | Downgrade | Societe Generale | Buy → Hold |
Jun-16-22 | Downgrade | UBS | Neutral → Sell |
Jan-20-22 | Downgrade | Jefferies | Buy → Hold |
Jan-14-22 | Upgrade | HSBC Securities | Hold → Buy |
Jan-12-22 | Downgrade | Citigroup | Buy → Neutral |
Sep-08-21 | Initiated | Jefferies | Buy |
Jul-08-21 | Downgrade | Deutsche Bank | Buy → Hold |
Jun-21-21 | Downgrade | HSBC Securities | Buy → Hold |
Mar-18-21 | Upgrade | JP Morgan | Neutral → Overweight |
Jul-28-20 | Initiated | Societe Generale | Buy |
Jul-30-19 | Initiated | Citigroup | Buy |
Feb-12-18 | Upgrade | Berenberg | Hold → Buy |
Nov-09-17 | Downgrade | JP Morgan | Overweight → Neutral |
Oct-16-17 | Downgrade | Exane BNP Paribas | Outperform → Neutral |
Jun-21-17 | Downgrade | Natixis Bleichroeder | Buy → Neutral |
Apr-25-17 | Downgrade | Societe Generale | Buy → Hold |
Dec-12-16 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
Nov-23-16 | Initiated | Citigroup | Buy |
May-11-16 | Upgrade | Exane BNP Paribas | Neutral → Outperform |
Mar-01-16 | Upgrade | HSBC Securities | Reduce → Hold |
Feb-16-16 | Downgrade | Jefferies | Hold → Underperform |
Nov-27-15 | Initiated | ING Group | Hold |
Sep-08-15 | Initiated | Credit Suisse | Outperform |
Aug-27-15 | Upgrade | Nomura | Neutral → Buy |
Jul-28-15 | Upgrade | Societe Generale | Hold → Buy |
Jan-25-11 | Downgrade | HSBC Securities | Overweight → Neutral |
Dec-07-09 | Upgrade | Deutsche Bank | Hold → Buy |
Oct-16-09 | Upgrade | HSBC Securities | Neutral → Overweight |
May-08-09 | Downgrade | UBS | Buy → Neutral |
View All
Koninklijke Philips N V Adr Stock (PHG) Latest News
CBRE Group Inc (CBRE) Stock: A Closer Look at the Market Potential - News Heater
Radiology Information System Market Forecast Report and Company Analysis 2025-2033 Featuring Koninklijke Philips, Siemens Healthcare, Oracle, McKesson, GE, Fujifilm, Shimadzu, Hologic, Sectra - GlobeNewswire Inc.
Taiwan Air Treatment Systems Industry Report: From AIoT to Wearables - GlobeNewswire Inc.
Selling Your Koninklijke Philips N.V. ADR (PHG) Stock? Here’s What You Need To Know - Stocks Register
Data-Based Insights About Koninklijke Philips N.V. ADR (PHG) - Stocks Register
Koninklijke Philips N.V. ADR (PHG) Shares Up Despite Recent Market Volatility - The News Heater
P3 Health Partners Inc (PIII) Stock: Evaluating the Annual Growth - The News Heater
Nabors Industries Ltd (NBR) Stock: A SWOT Analysis - The News Heater
Sun Country Airlines Holdings Inc (SNCY) Stock: A Value Analysis - The News Heater
Weekly Stock Grader Analysis: Upgrades & Downgrades on Top Blue-Chip Stocks - InvestorPlace
Sony Group Corp. ADR rises Wednesday, outperforms market - MarketWatch
Weekly Upgrades and Downgrades - InvestorPlace
Europe Cancer Diagnostics Market Size & Outlook, 2024-2030 - Grand View Research
Picture Archiving and Communication System Patent Landscape Report, 2024-2032 - GlobeNewswire Inc.
Germany Home Healthcare Market Forecast Report 2024-2032 - GlobeNewswire Inc.
Validea Kenneth Fisher Strategy Daily Upgrade Report10/29/2024 - Nasdaq
Latin America Household Cooking Appliance Market Size & Outlook, 2030 - Grand View Research
Philips has another Class I level ventilator recall - Mass Device
PHG vs. ESLOY: Which Stock Is the Better Value Option? - Yahoo Finance
South Africa Smart Home Appliances Market Size & Outlook, 2030 - Grand View Research
China Refurbished Medical Imaging Devices Market Size & Outlook, 2030 - Grand View Research
China Operating Room Equipment Market Size & Outlook, 2030 - Grand View Research
Middle East & Africa Doppler Ultrasound Market Size & Outlook, 2030 - Grand View Research
New 4-Star Stocks - Morningstar
Germany Diagnostic Imaging Market Size & Outlook, 2030 - Grand View Research
Saudi Arabia Pancreatic Cancer Diagnostic Market Size & Outlook, 2030 - Grand View Research
Philips to repurchase shares for up to $137.4M - Mass Device
Philips stock rises on Street-beating Q2 - Mass Device
Philips inks new multi-year patient monitoring collab - Mass Device
Philips wins FDA clearance for next-gen digital pathology system - Mass Device
GE HealthCare: Initiating Coverage With Wide Moat, Shares Look Attractive - Morningstar
Philips unveils new AI-powered cardiovascular ultrasound - Mass Device
Philips prices $758.6M offering, expands access to intracardiac echocardiography - Mass Device
Philips has positive AI-powered cardiac monitoring data - Mass Device
Philips announces exchange ratio for 2023 dividend - Philips
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement - Morningstar
Philips creates 'clear path forward' with FDA over Respironics probe - Sharecast.com
With 48% ownership in Koninklijke Philips N.V. (AMS:PHIA), institutional investors have a lot riding on the business - Yahoo Finance
Koninklijke Philips N V Adr Stock (PHG) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):